axicabtagene ciloleucel,fludarabine,cyclophosphamide
gilead
['axi-cel', 'zuma-5', 'lymsm']
#eha2023 caron jacobson presents real-world outcomes for patients with r/r fl eligible and ineligible for the zuma-5 trial. results show effectiveness (93%; 95% ci, 88-97 achieved or) and a manageable safety profile to support broader use of axi-cel for r/r fl #lymsm 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm